We are determined to contribute to public health and
through our ongoing development of
innovative diagnostic technologies.
- In Vitro Diagnostic Reagents
- We provide high-quality clinical diagnostics reagents for autoimmune diseases and genetic testing, targeted for clinical laboratories and hospitals.
- Customized Companion Diagnostics
- To support drug development, MBL provides contract services for development of companion diagnostics.
Nov 27, 2023Improved ELISA kits for measuring human antibodies against Adeno-Associated Virus 2 (AAV2) or 5 (AAV5) are now available!
Improved within-run reproducibility and accuracy compared to conventional products. For research on gene therapy using AAV!
Oct 23, 2023MBL’s Recombinant Human R-spondin 1 is now available!
A recombinant protein with the bioactive domain developed at MBL. For organoid research!
Oct 03, 2023An ELISA kit for measuring anti-Adeno-Associated Virus 8 (AAV8) antibodies for human is now available.
A new kit for AAV8 serotype of human with improved within-run reproducibility and accuracy compared to conventional product. For research on gene therapy using AAV!